by Loren Bonner
, DOTmed News Online Editor | April 10, 2014
Dr. Steven Frank, director of Advanced Technologies of the Proton Therapy Center at the University of Texas MD Anderson Cancer Center, said they have seen prostate procedures going down, and more head and neck cases being treated.
Dr. Nancy Mendenhall, medical director at the University of Florida Proton Therapy Institute, said in 2013 they saw a decreasing percentage of prostate cancer cases — down from 90 percent to 45 percent, currently.
New marketing message
Quest Imaging Solutions provides all major brands of surgical c-arms (new and refurbished) and carries a large inventory for purchase or rent. With over 20 years in the medical equipment business we can help you fulfill your equipment needs
Many speakers spoke about finding ways to better identify those patients who would benefit the most from proton therapy.
"It should be more about the benefits to specific patients," said Pericak.
Going forward, he thinks proton therapy's marketing message should be less about being the best treatment, to targeting who it's best for. Back to HCB News